Carme Costa

Bellaterra, CT 08193, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Angiogenin in the Neurogenic Subventricular Zone After Stroke.

Angiogenin in the Neurogenic Subventricular Zone After Stroke.

Journal: Frontiers in neurology
Published: January 31, 2021

Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis.

Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: January 26, 2021

Inhibition of the BMP Signaling Pathway Ameliorated Established Clinical Symptoms of Experimental Autoimmune Encephalomyelitis.

Inhibition of the BMP Signaling Pathway Ameliorated Established Clinical Symptoms of Experimental Autoimmune Encephalomyelitis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: July 19, 2020

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS.

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: May 06, 2020

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.

Journal: Brain : a journal of neurology
Published: September 21, 2019

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients.

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients.

Journal: Journal of neuroinflammation
Published: June 25, 2018

Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.

Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.

Journal: Journal of neuroinflammation
Published: May 28, 2018

Expression of Bone Morphogenetic Proteins in Multiple Sclerosis Lesions.

Expression of Bone Morphogenetic Proteins in Multiple Sclerosis Lesions.

Journal: The American journal of pathology
Published: May 17, 2018

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 09, 2017

Generation of six multiple sclerosis patient-derived induced pluripotent stem cell lines.

Generation of six multiple sclerosis patient-derived induced pluripotent stem cell lines.

Journal: Stem cell research
Published: April 19, 2017

Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis.

Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis.

Journal: Molecular neurobiology
Published: June 16, 2016

Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis.

Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis.

Journal: Experimental neurology
Published: May 19, 2016
Showing 1-12 of 26

Last Updated: 09/26/2026